Pooja Rani | Pharmaceutical sciences | Best Researcher Award

Dr. Pooja Rani | Pharmaceutical sciences | Best Researcher Award

CGC University | India

Dr. Pooja Rani is an accomplished pharmaceutical scientist and academician currently serving as an Assistant Professor, with expertise spanning pharmaceutics, drug delivery systems, and translational pharmaceutical research. She holds a doctoral degree in Pharmaceutical Sciences along with postgraduate and undergraduate training in Pharmacy, building a strong foundation in formulation development and therapeutic design. Her teaching and administrative experience across reputed institutions includes curriculum delivery, research mentoring, academic coordination, and student development initiatives. Dr. Rani’s research interests focus on natural polymer–based nanofibers, gastroretentive drug delivery systems, microneedles, microsponge technology, and quality-by-design approaches for advanced formulations. She has authored numerous research and review articles in high-impact, peer-reviewed journals, contributed to books, and holds a granted patent in biomedical diagnostics. Her scholarly contributions have been recognized with a Best Researcher Award for outstanding publication impact. Through her integrated role as educator, researcher, and innovator, Dr. Rani continues to advance pharmaceutical science with a commitment to patient-centric and sustainable drug development.

Citation Metrics (Scopus)

15
10
5
0

Citations
12

Documents
2

h-index
2

Citations

Documents

h-index



View Scopus Author Profile

Featured Publications

In Silico Screening of Phytoconstituents and Medicinal Plants as Antidiabetic Drug Discovery

Corrosion Management (ISSN: 1355-5243), 34(2), 227–245 · 1 Citation · 2024

From nature to nurture: A review on the escalating role of locust bean gum in food, pharma, and cosmeceuticals

International Journal of Biological Macromolecules, Article 149376 · 2025

Stem Cells to Organoids: Pioneering the Future of Regenerative Therapies

Stem Cell Reviews and Reports, 1–26 · 2025